Voloridge Investment Management
APLT

Voloridge Investment Management’s Applied Therapeutics APLT Stock Holding History

Voloridge Investment Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,463
Closed -$293K – 1168
2024
Q3 		$293K Buy
+34,463
New +$203K ﹤0.01% 1114

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Voloridge Investment Management's APLT Position: Q4 2024 in Review

Voloridge Investment Management sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 34,463 shares — an estimated $293K sold.

Voloridge Investment Management first reported a position in APLT in Q3 2024 and held it in 1 quarter. The position peaked at $293K in Q3 2024. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Voloridge Investment Management reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 34,463 Applied Therapeutics shares in Q4 2024, an estimated $293K.
  • Voloridge Investment Management first reported a position in Applied Therapeutics in Q3 2024 and held it in 1 quarter.
  • Voloridge Investment Management's Applied Therapeutics position peaked at $293K in Q3 2024.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.